首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1361765

全球移植药物监测分析市场报告

Global Transplant Drug Monitoring Assay Market Report

出版日期: 2023年10月01日 | 出版商:

Value Market Research | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到 2030 年，全球移植药物监测检测市场的市场规模将从 2022 年的 212.72 万美元达到近 645.2 万美元，2023-2030 年研究期间的复合年增长率为 13.12%。

移植药物监测测定对于帮助医疗保健专业人员将免疫抑制剂的血浆和血液水平维持在各自的治疗范围内至关重要。移植药物监测测定从开始用药开始。它包括确定患者可接受的初步剂量方案和临床状态特征，例如年龄、体重指数、体重、器官功能和药物治疗。

市场动态：

推动市场成长的因素包括器官移植需求的增加、研发资金的增加以及肾臟疾病等慢性病盛行率的增加。此外，在预测期内，对床边治疗药物监测和家庭治疗药物监测的需求增加可能为全球移植药物监测分析产业的参与者提供利润丰厚的市场机会。此外，医疗保健支出的增加、医疗保健基础设施的改善、全球人均收入的增加以及政府报销计划预计将在未来几年为移植药物监测检测市场带来盈利前景。然而，需要巨额投资以及小型医院不愿提供移植药物监测检测服务可能会阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球移植药物监测分析市场的每个细分市场进行了包容性评估。移植药物监测分析产业的成长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲移植药物监测检测市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。移植药物监测检测市场的主要参与者包括 Abbott、Thermo Fisher Scientific Inc.、HU Group Holdings Inc. (Fujirebio Holdings, Inc.)、Hoffmann-La Roche Ltd.、Siemens Healthineers AG、Hologic Inc.、Danaher Corporation、 Bio -Rad Laboratories Inc.，其他知名企业。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概述、历史和预测销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 11 章：移植药物监测分析公司的竞争格局

移植药物监测分析市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 12 章：公司简介

顶尖公司股票分析
市场集中度
Abbott

公司简介
公司收入
产品
最近的发展

Thermo Fisher Scientific Inc.

公司简介
公司收入
产品
最近的发展

HU Group Holdings Inc.

公司简介
公司收入
产品
最近的发展

Fujirebio Holdings Inc.

公司简介
公司收入
产品
最近的发展

Hoffmann-La Roche Ltd.

公司简介
公司收入
产品
最近的发展

Siemens Healthineers AG

公司简介
公司收入
产品
最近的发展

Hologic Inc.

公司简介
公司收入
产品
最近的发展

Danaher Corporation

公司简介
公司收入
产品
最近的发展

Bio-Rad Laboratories Inc.

公司简介
公司收入
产品
最近的发展

Other Prominent Players

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR11218699

The global demand for Transplant Drug Monitoring Assay Market is presumed to reach the market size of nearly USD 645.2 MN by 2030 from USD 212.72 MN in 2022 with a CAGR of 13.12% under the study period 2023 - 2030.

Transplant drug monitoring assay is crucial in helping health care professionals maintain plasma and blood levels of immunosuppressants within their respective therapeutic ranges. Transplant drug monitoring assay starts with the initiation of medication. It includes the determination of a preliminary dosage regimen acceptable for the patient and clinical state characteristics such as age, body mass index, weight, organ function and drug therapy.

MARKET DYNAMICS:

The factors fueling the market growth are the increased demand for organ transplants, increased R&D funding, and an increase in the prevalence of chronic diseases such as kidney diseases. Moreover, an increase in the need for point-of-care therapeutic drug monitoring and home-based therapeutic drug monitoring is likely to offer lucrative market opportunities for players operating in the global transplant drug monitoring assay industry during the forecast period. Additionally, a rise in healthcare expenditure, improvement in healthcare infrastructure, increase in global per capita income, and government reimbursement programs are projected to present profitable prospects in the transplant drug monitoring assay market in the upcoming years. However, the need for huge investments and the reluctance of small hospitals to offer transplant drug monitoring assay services may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of transplant drug monitoring assay. The growth and trends of transplant drug monitoring assay industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the transplant drug monitoring assay market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Equipment
Consumables (Chromatography & Ms Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers)

By Technology

Chromatography-Ms
Immunoassays

By Drug

Tacrolimus
Methotrexate
Cyclosporin
Others

By End-User

Hospital Laboratories
Commercial & Private Laboratories
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Transplant Drug Monitoring Assay market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Transplant Drug Monitoring Assay market include Abbott, Thermo Fisher Scientific Inc., H.U. Group Holdings Inc. (Fujirebio Holdings, Inc.), Hoffmann-La Roche Ltd., Siemens Healthineers AG, Hologic Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Other prominent players. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . TRANSPLANT DRUG MONITORING ASSAY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Drug
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Equipment Historic and Forecast Sales by Regions
6.5 Consumables (Chromatography & MS Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers) Historic and Forecast Sales by Regions

7 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY TECHNOLOGY

7.1 Overview by Technology
7.2 Historical and Forecast Data
7.3 Analysis by Technology
7.4 Chromatography-MS Historic and Forecast Sales by Regions
7.5 Immunoassays Historic and Forecast Sales by Regions

8 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY DRUG

8.1 Overview by Drug
8.2 Historical and Forecast Data
8.3 Analysis by Drug
8.4 Tacrolimus Historic and Forecast Sales by Regions
8.5 Methotrexate Historic and Forecast Sales by Regions
8.6 Cyclosporin Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY END-USER

9.1 Overview by End-user
9.2 Historical and Forecast Data
9.3 Analysis by End-user
9.4 Hospital Laboratories Historic and Forecast Sales by Regions
9.5 Commercial & Private Laboratories Historic and Forecast Sales by Regions
9.6 Others Historic and Forecast Sales by Regions

10 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE TRANSPLANT DRUG MONITORING ASSAY COMPANIES

11.1. Transplant Drug Monitoring Assay Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF TRANSPLANT DRUG MONITORING ASSAY INDUSTRY

12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. Abbott
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Thermo Fisher Scientific Inc.
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. H.U. Group Holdings Inc.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Fujirebio Holdings Inc.
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Hoffmann-La Roche Ltd.
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Siemens Healthineers AG
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Hologic Inc.
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Danaher Corporation
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. Bio-Rad Laboratories Inc.
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. Other Prominent Players
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Product (USD MN)
Equipment Market Sales by Geography (USD MN)
Consumables (Chromatography & MS Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers) Market Sales by Geography (USD MN)
Analysis Market by Technology (USD MN)
Chromatography-MS Market Sales by Geography (USD MN)
Immunoassays Market Sales by Geography (USD MN)
Analysis by Drug (USD MN)
Tacrolimus Market Sales by Geography (USD MN)
Methotrexate Market Sales by Geography (USD MN)
Cyclosporin Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis by End-user (USD MN)
Hospital Laboratories Market Sales by Geography (USD MN)
Commercial & Private Laboratories Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Transplant Drug Monitoring Assay Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Transplant Drug Monitoring Assay Report
Market Research Process
Market Research Methodology
Global Transplant Drug Monitoring Assay Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product
Market Attractiveness Analysis by Technology
Market Attractiveness Analysis by Drug
Market Attractiveness Analysis by End-user
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis Product (USD MN)
Equipment Market Sales by Geography (USD MN)
Consumables (Chromatography & MS Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers) Market Sales by Geography (USD MN)
Global Market Analysis by Technology (USD MN)
Chromatography-MS Market Sales by Geography (USD MN)
Immunoassays Market Sales by Geography (USD MN)
Global Market Analysis by Drug (USD MN)
Tacrolimus Market Sales by Geography (USD MN)
Methotrexate Market Sales by Geography (USD MN)
Cyclosporin Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by End-user (USD MN)
Hospital Laboratories Market Sales by Geography (USD MN)
Commercial & Private Laboratories Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Top Company Share Analysis